While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid out the ...

FDA commissioner Robert Califf’s second term is anticipated to end in 2025, and all eyes are now on who will be the next to ...

Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered ...

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...

Trump has promised he would allow Robert F. Kennedy Jr. to "go wild" on medicines, food, and health. With that, a radical antiestablishment medical movement with roots in past centuries could threaten ...

At a cancer research event Tuesday, FDA Commissioner Robert Califf said he was “disappointed” with the election results and ...

Robert F. Kennedy, Jr. has fanned the flames of vaccine misinformation and elevated unfounded claims about corruption within ...

Food and Drug Administration commissioner Robert Califf said he was “disappointed” with the presidential election result and ...

Federal health scientists voice concern over an anticipated takeover by medical skeptics in Trump’s second administration ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Robert F. Kennedy Jr. has promised to "make America healthy again." What does that actually mean? Here's everything he ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...